PTC Therapeutics to Present Innovations at R&D Day on December 2, 2025

PTC Therapeutics to Showcase Innovative Developments at Upcoming R&D Day

PTC Therapeutics, Inc. is gearing up for an important Research and Development (R&D) Day scheduled for December 2, 2025, at 9:30 a.m. EST in New York City, with a concurrent webcast option for remote participants. This event will feature insights from CEO Dr. Matthew B. Klein and the research and development team, who will provide updates on the company's cutting-edge small molecule splicing and inflammation platforms. PTC Therapeutics aims to highlight new targets and programs within its pipeline that are pivotal in addressing rare disorders, affirming its position as a leader in the biopharmaceutical field.

The focus of the R&D Day will be on PTC’s commitment to innovation in therapies for rare diseases, which have historically been underserved in the pharmaceutical market. By leveraging its scientific expertise, the company is dedicated to discovering and developing differentiated medicines that can transform patient outcomes. This strategic emphasis on both small molecule splicing and inflammation platforms positions PTC at the forefront of innovative treatments, reflecting its resolve to meet the significant unmet medical needs of patients affected by rare disorders.

Furthermore, PTC Therapeutics underscores its mission to enhance treatment accessibility for both children and adults grappling with these conditions. As the company continues to build its pipeline, the R&D Day serves as a pivotal platform to communicate its progress and future directions. Interested stakeholders can register for the webcast through the PTC Therapeutics website, where a replay will also be available for approximately 30 days following the event, ensuring broader access to the information shared.

In addition to the upcoming R&D Day, PTC Therapeutics maintains an active presence on social media platforms, providing updates and engaging with its community. The company's dedication to transparency and communication highlights its commitment to advancing healthcare solutions for patients with rare diseases. For those interested in learning more about PTC Therapeutics and its innovative initiatives, the company encourages visits to their website and participation in its online discussions.